{
  "DOI": "10.1186/s40246-019-0250-2",
  "ISSN": [
    "1479-7364"
  ],
  "URL": "http://dx.doi.org/10.1186/s40246-019-0250-2",
  "abstract": "\u003cjats:title\u003eAbstract\u003c/jats:title\u003e\u003cjats:sec\u003e\n\u003cjats:title\u003eBackground\u003c/jats:title\u003e\n\u003cjats:p\u003eSince the discovery of cell-free DNA (cfDNA) in maternal plasma, it has opened up new approaches for non-invasive prenatal testing. With the development of whole-genome sequencing, small subchromosomal deletions and duplications could be found by NIPT. This study is to review the efficacy of NIPT as a screening test for aneuploidies and CNVs in 42,910 single pregnancies.\u003c/jats:p\u003e\n\u003c/jats:sec\u003e\u003cjats:sec\u003e\n\u003cjats:title\u003eMethods\u003c/jats:title\u003e\n\u003cjats:p\u003eA total of 42,910 single pregnancies with different clinical features were recruited. The cell-free fetal DNA was directly sequenced. Each of the chromosome aneuploidies and the subchromosomal microdeletions/microduplications of PPV were analyzed.\u003c/jats:p\u003e\n\u003c/jats:sec\u003e\u003cjats:sec\u003e\n\u003cjats:title\u003eResults\u003c/jats:title\u003e\n\u003cjats:p\u003eA total of 534 pregnancies (1.24%) were abnormal results detected by NIPT, and 403 pregnancies had underwent prenatal diagnosis. The positive predictive value (PPV) for trisomy 21(T21), trisomy 18 (T18), trisomy 13 (T13), sex chromosome aneuploidies (SCAs), and other chromosome aneuploidy was 79.23%, 54.84%, 13.79%, 33.04%, and 9.38% respectively. The PPV for CNVs was 28.99%. The PPV for CNVs ≤ 5 Mb is 20.83%, for within 5–10 Mb 50.00%, for \u0026gt; 10 Mb 27.27% respectively. PPVs of NIPT according to pregnancies characteristics are also different.\u003c/jats:p\u003e\n\u003c/jats:sec\u003e\u003cjats:sec\u003e\n\u003cjats:title\u003eConclusion\u003c/jats:title\u003e\n\u003cjats:p\u003eOur data have potential significance in demonstrating the usefulness of NIPT profiling not only for common whole chromosome aneuploidies but also for CNVs. However, this newest method is still in its infancy for CNVs. There is still a need for clinical validation studies with accurate detection rates and false positive rates in clinical practice.\u003c/jats:p\u003e\n\u003c/jats:sec\u003e",
  "alternative-id": [
    "250"
  ],
  "article-number": "60",
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "30 June 2019"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 2,
      "value": "15 November 2019"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 3,
      "value": "29 November 2019"
    },
    {
      "group": {
        "label": "Ethics approval and consent to participate",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1,
      "value": "This study was approved by the Ethics Committee of Ningbo Women and Children Hospital."
    },
    {
      "group": {
        "label": "Consent for publication",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "The authors declare that they have no competing interests and the patients in this case report had provided their consent for publication."
    },
    {
      "group": {
        "label": "Competing interests",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 3,
      "value": "The authors declare that they have no competing interests."
    }
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Chen",
      "given": "Yibo",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Yu",
      "given": "Qi",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Mao",
      "given": "Xiongying",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Lei",
      "given": "Wei",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "He",
      "given": "Miaonan",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Lu",
      "given": "Wenbo",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Human Genomics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2019,
        11,
        29
      ]
    ],
    "date-time": "2019-11-29T15:03:04Z",
    "timestamp": 1575039784000
  },
  "deposited": {
    "date-parts": [
      [
        2020,
        11,
        28
      ]
    ],
    "date-time": "2020-11-28T00:16:21Z",
    "timestamp": 1606522581000
  },
  "funder": [
    {
      "award": [
        "No. 2018KY720"
      ],
      "name": "Zhejiang Medical and Health Science and Technology Plan Project"
    }
  ],
  "indexed": {
    "date-parts": [
      [
        2024,
        4,
        16
      ]
    ],
    "date-time": "2024-04-16T07:16:35Z",
    "timestamp": 1713251795390
  },
  "is-referenced-by-count": 75,
  "issn-type": [
    {
      "type": "electronic",
      "value": "1479-7364"
    }
  ],
  "issue": "1",
  "issued": {
    "date-parts": [
      [
        2019,
        11,
        29
      ]
    ]
  },
  "journal-issue": {
    "issue": "1",
    "published-print": {
      "date-parts": [
        [
          2019,
          12
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://creativecommons.org/licenses/by/4.0/",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2019,
            11,
            29
          ]
        ],
        "date-time": "2019-11-29T00:00:00Z",
        "timestamp": 1574985600000
      }
    },
    {
      "URL": "http://creativecommons.org/licenses/by/4.0/",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2019,
            11,
            29
          ]
        ],
        "date-time": "2019-11-29T00:00:00Z",
        "timestamp": 1574985600000
      }
    }
  ],
  "link": [
    {
      "URL": "http://link.springer.com/content/pdf/10.1186/s40246-019-0250-2.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/article/10.1186/s40246-019-0250-2/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1186/s40246-019-0250-2.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "prefix": "10.1186",
  "published": {
    "date-parts": [
      [
        2019,
        11,
        29
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2019,
        11,
        29
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2019,
        12
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "key": "250_CR1",
      "unstructured": "Lo, Y.M., et al., Presence of fetal DNA in maternal plasma and serum. 1997. 350(9076): p. 485-487."
    },
    {
      "DOI": "10.1002/pd.4637",
      "doi-asserted-by": "crossref",
      "key": "250_CR2",
      "unstructured": "Minear, M.A., et al., Global perspectives on clinical adoption of NIPT. 2015. 35(10): p. 959-967."
    },
    {
      "DOI": "10.1002/uog.14791",
      "doi-asserted-by": "crossref",
      "key": "250_CR3",
      "unstructured": "Gil, M.M., et al., Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis. 2015. 45(3): p. 249-266."
    },
    {
      "DOI": "10.1002/uog.14792",
      "doi-asserted-by": "crossref",
      "key": "250_CR4",
      "unstructured": "Zhang, H., et al., Non-invasive prenatal testing for trisomies 21, 18 and 13: clinical experience from 146,958 pregnancies. 2015. 45(5): p. 530-538."
    },
    {
      "DOI": "10.1371/journal.pone.0109173",
      "author": "RM McCullough",
      "doi-asserted-by": "publisher",
      "first-page": "e109173",
      "issue": "10",
      "journal-title": "PLoS One",
      "key": "250_CR5",
      "unstructured": "McCullough RM, et al. Non-invasive prenatal chromosomal aneuploidy testing--clinical experience: 100,000 clinical samples. PLoS One. 2014;9(10):e109173.",
      "volume": "9",
      "year": "2014"
    },
    {
      "DOI": "10.2174/1566524016666161013142335",
      "doi-asserted-by": "crossref",
      "key": "250_CR6",
      "unstructured": "Hu, H., et al., Clinical experience of non-invasive prenatal chromosomal aneuploidy testing in 190,277 Patient Samples. 2016. 16(8): p. -."
    },
    {
      "DOI": "10.1371/journal.pone.0109173",
      "doi-asserted-by": "crossref",
      "key": "250_CR7",
      "unstructured": "Mccullough, R.M., et al., Non-invasive prenatal chromosomal aneuploidy testing - clinical experience: 100,000 Clinical Samples. 2014. 9(10): p. e109173."
    },
    {
      "DOI": "10.1186/s40246-019-0198-2",
      "doi-asserted-by": "crossref",
      "key": "250_CR8",
      "unstructured": "Hu, H., et al., Noninvasive prenatal testing for chromosome aneuploidies and subchromosomal microdeletions/microduplications in a cohort of 8141 single pregnancies. 2019. 13(1): p. 14."
    },
    {
      "DOI": "10.1038/s41436-019-0467-4",
      "doi-asserted-by": "crossref",
      "key": "250_CR9",
      "unstructured": "Liang D, et al. Clinical utility of noninvasive prenatal screening for expanded chromosome disease syndromes. Genet Med. 2019."
    },
    {
      "DOI": "10.1002/pd.4710",
      "author": "NC Rose",
      "doi-asserted-by": "publisher",
      "first-page": "10",
      "issue": "1",
      "journal-title": "Prenat Diagn",
      "key": "250_CR10",
      "unstructured": "Rose NC, Benn P, Milunsky A. Current controversies in prenatal diagnosis 1: should NIPT routinely include microdeletions/microduplications? Prenat Diagn. 2016;36(1):10–4.",
      "volume": "36",
      "year": "2016"
    },
    {
      "DOI": "10.1016/j.ajog.2016.04.029",
      "doi-asserted-by": "crossref",
      "key": "250_CR11",
      "unstructured": "Evans, M.I., et al., Noninvasive prenatal screening or advanced diagnostic testing: caveat emptor. 2016. 215(3): p. 298-305."
    },
    {
      "DOI": "10.1371/journal.pone.0171319",
      "author": "MC Neofytou",
      "doi-asserted-by": "publisher",
      "issue": "2",
      "journal-title": "PLoS One",
      "key": "250_CR12",
      "unstructured": "Neofytou MC, et al. Targeted capture enrichment assay for non-invasive prenatal testing of large and small size sub-chromosomal deletions and duplications. PLoS One. 2017;12(2):e0171319.",
      "volume": "12",
      "year": "2017"
    },
    {
      "DOI": "10.1097/AOG.0000000000001091",
      "author": "Y Yaron",
      "doi-asserted-by": "publisher",
      "first-page": "1095",
      "issue": "5",
      "journal-title": "Obstet Gynecol",
      "key": "250_CR13",
      "unstructured": "Yaron Y, et al. Current status of testing for microdeletion syndromes and rare autosomal trisomies using cell-free DNA technology. Obstet Gynecol. 2015;126(5):1095–9.",
      "volume": "126",
      "year": "2015"
    },
    {
      "DOI": "10.1056/NEJMoa1407349",
      "author": "E Mary",
      "doi-asserted-by": "publisher",
      "first-page": "1589",
      "journal-title": "N Engl J Med",
      "key": "250_CR14",
      "unstructured": "Mary E, et al. Cell-free DNA analysis for noninvasive examination of trisomy. N Engl J Med. 2015;372:1589–97.",
      "volume": "372",
      "year": "2015"
    },
    {
      "DOI": "10.1007/s40556-017-0116-4",
      "doi-asserted-by": "crossref",
      "key": "250_CR15",
      "unstructured": "Verma, I.C., R. Dua-Puri, and S.J.J.o.F.M. Bijarnia-Mahay, ACMG 2016 update on noninvasive prenatal testing for fetal aneuploidy: implications for India. 2017. 4(1): p. 1-6."
    },
    {
      "DOI": "10.1038/gim.2013.126",
      "doi-asserted-by": "crossref",
      "key": "250_CR16",
      "unstructured": "Lutgendorf, M.A., et al., Noninvasive prenatal testing: limitations and unanswered questions. 2014. 16(4): p. 281-285."
    },
    {
      "DOI": "10.1002/pd.5217",
      "doi-asserted-by": "crossref",
      "key": "250_CR17",
      "unstructured": "Schwartz, S., et al., clinical experience of laboratory follow-up with non-invasive prenatal testing using cell-free DNA and positive microdeletion results in 349 cases. 2018."
    },
    {
      "DOI": "10.2353/ajpath.2006.060161",
      "doi-asserted-by": "crossref",
      "key": "250_CR18",
      "unstructured": "Tjoa, M.L., et al., Trophoblastic oxidative stress and the release of cell-free feto-placental DNA. 2006. 169(2): p. 400-404."
    },
    {
      "DOI": "10.1002/ajmg.c.31505",
      "doi-asserted-by": "crossref",
      "key": "250_CR19",
      "unstructured": "Mardy, A. and R.J.J.A.J.o.M.G.P.C.S.i.M.G. Wapner, Confined placental mosaicism and its impact on confirmation of NIPT results. 2016. 172(2): p. 118-122."
    },
    {
      "DOI": "10.1038/gim.2014.3",
      "doi-asserted-by": "crossref",
      "key": "250_CR20",
      "unstructured": "Grati, F.R., et al., Fetoplacental mosaicism: potential implications for false-positive and false-negative noninvasive prenatal screening results. 2014. 16(8): p. 620."
    },
    {
      "DOI": "10.1038/gim.2016.97",
      "doi-asserted-by": "crossref",
      "key": "250_CR21",
      "unstructured": "Gregg, A.R., et al., Noninvasive prenatal screening for fetal aneuploidy, 2016 update: a position statement of the American College of Medical Genetics and Genomics. 2016. 18(10): p. 1056-1065."
    },
    {
      "author": "ME Norton",
      "first-page": "1589",
      "issue": "17",
      "journal-title": "Cell-free DNA analysis for noninvasive examination of trisomy.",
      "key": "250_CR22",
      "unstructured": "Norton ME. et al. Cell-free DNA analysis for noninvasive examination of trisomy. 2015;372(17):1589–97.",
      "volume": "372",
      "year": "2015"
    },
    {
      "DOI": "10.1097/MD.0000000000007114",
      "doi-asserted-by": "crossref",
      "key": "250_CR23",
      "unstructured": "Yu, B., et al., Overall evaluation of the clinical value of prenatal screening for fetal-free DNA in maternal blood. 2017. 96(27): p. e7114."
    },
    {
      "DOI": "10.1146/annurev-genet-102209-163544",
      "doi-asserted-by": "crossref",
      "key": "250_CR24",
      "unstructured": "Girirajan, S., C.D. Campbell, and E.E.J.A.R.o.G. Eichler, Human copy number variation and complex genetic disease. 2011. 45(1): p. 203-226."
    },
    {
      "DOI": "10.1056/NEJMoa1203382",
      "author": "RJ Wapner",
      "doi-asserted-by": "publisher",
      "first-page": "2175",
      "issue": "23",
      "journal-title": "N Engl J Med",
      "key": "250_CR25",
      "unstructured": "Wapner RJ, et al. Chromosomal microarray versus karyotyping for prenatal diagnosis. N Engl J Med. 2012;367(23):2175–84.",
      "volume": "367",
      "year": "2012"
    },
    {
      "key": "250_CR26",
      "unstructured": "Miller, D.T., et al., Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. 2010. 86(5): p. 749-764."
    },
    {
      "DOI": "10.1097/GIM.0b013e3181f8baad",
      "doi-asserted-by": "crossref",
      "key": "250_CR27",
      "unstructured": "Melanie, M. and H.J.G.i.M. Louanne, Array-based technology and recommendations for utilization in medical genetics practice for detection of chromosomal abnormalities. 2010. 12(11): p. 742-745."
    },
    {
      "DOI": "10.1055/s-0036-1587794",
      "doi-asserted-by": "crossref",
      "key": "250_CR28",
      "unstructured": "Niederstrasser, S.L., et al., Fetal loss following invasive prenatal testing: a comparison of transabdominal chorionic villus sampling, transcervical chorionic villus sampling and amniocentesis. 2016. 37(S 01)."
    },
    {
      "DOI": "10.1159/000271995",
      "author": "A Tabor",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "issue": "1",
      "journal-title": "Fetal Diagn Ther",
      "key": "250_CR29",
      "unstructured": "Tabor A, Alfirevic Z. Update on procedure-related risks for prenatal diagnosis techniques. Fetal Diagn Ther. 2010;27(1):1–7.",
      "volume": "27",
      "year": "2010"
    },
    {
      "DOI": "10.1016/j.ajhg.2012.12.006",
      "author": "A Srinivasan",
      "doi-asserted-by": "publisher",
      "first-page": "167",
      "issue": "2",
      "journal-title": "Am J Hum Genet",
      "key": "250_CR30",
      "unstructured": "Srinivasan A, et al. Noninvasive detection of fetal subchromosome abnormalities via deep sequencing of maternal plasma. Am J Hum Genet. 2013;92(2):167–76.",
      "volume": "92",
      "year": "2013"
    },
    {
      "DOI": "10.1111/cge.13098",
      "author": "K Martin",
      "doi-asserted-by": "publisher",
      "first-page": "293",
      "issue": "2",
      "journal-title": "Clin Genet",
      "key": "250_CR31",
      "unstructured": "Martin K, et al. Clinical experience with a single-nucleotide polymorphism-based non-invasive prenatal test for five clinically significant microdeletions. Clin Genet. 2018;93(2):293–300.",
      "volume": "93",
      "year": "2018"
    },
    {
      "DOI": "10.1016/j.ajog.2004.03.090",
      "doi-asserted-by": "crossref",
      "key": "250_CR32",
      "unstructured": "Nicolaides, K.H., %J American Journal of Obstetrics and Gynecology, Nuchal translucency and other first-trimester sonographic markers of chromosomal abnormalities. 2004. 191(1): p. 45-67."
    },
    {
      "DOI": "10.1159/000357564",
      "doi-asserted-by": "crossref",
      "key": "250_CR33",
      "unstructured": "Ching-Hua, H., et al., Extended first-trimester screening using multiple sonographic markers and maternal serum biochemistry: a five-year prospective study. 2014. 35(4): p. 296-301."
    },
    {
      "DOI": "10.1182/blood-2006-06-031351",
      "doi-asserted-by": "crossref",
      "key": "250_CR34",
      "unstructured": "Gonzalez Garcia, J.R. and J.P.J.B. Mezaespinoza, International system for human cytogenetic nomenclature (ISCN). 2006. 108(12): p. 3952."
    }
  ],
  "reference-count": 34,
  "references-count": 34,
  "resource": {
    "primary": {
      "URL": "https://humgenomics.biomedcentral.com/articles/10.1186/s40246-019-0250-2"
    }
  },
  "score": 0,
  "short-container-title": [
    "Hum Genomics"
  ],
  "source": "Crossref",
  "title": [
    "Noninvasive prenatal testing for chromosome aneuploidies and subchromosomal microdeletions/microduplications in a cohort of 42,910 single pregnancies with different clinical features"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "13"
}